James Rusnak
7Patents
3h-index
6Co-inventors
46Inventor score
Filing activity: Aug 3, 2004 → Oct 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7307064B2 | Methods for treating cardiovascular disease using a soluble CTLA4 molecule | Chemistry; Metallurgy | 32 | Expired |
| US7482327B2 | Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules | Chemistry; Metallurgy | 17 | Expired |
| US7671022B2 | Methods for treating cardiovascular disease using a soluble CTLA4 molecule | Chemistry; Metallurgy | 5 | Active |
| US10285973B2 | SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease | Human Necessities | 0 | Active |
| US12036203B2 | Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors | Human Necessities | 0 | Active |
| US10500186B2 | SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease | Human Necessities | 0 | Active |
| US10709684B2 | SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.